01 HTL S.A.S. Javené FR (1)
01 Sodium hyaluronate, Alternative process, not less than 1.6m3/kg, by fermentation, for parenteral administration including intra-articular administration, and for intra-ocular use. (1)
01 France (1)
01 Valid (1)
20
Htl S.a.s. Javené Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for HTL Biotechnology is the world leader in the responsible development and production of pharmaceutical-grade biopolymers.
One of their significant offerings is Sodium hyaluronate, Alternative process, not less than 1.6m3/kg, by fermentation, for parenteral administration including intra-articular administration, and for intra-ocular use., supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-266 - Rev 02
This Chemical Type CEP, issued on July 03, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1472 associated with this CEP further emphasizes